Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

BACKGROUND: Immunotherapies have demonstrated clinical benefit for many types of cancers, however many patients do not respond, and treatment-related adverse effects can be severe. Hence many efforts are underway to identify treatment predictive biomarkers. We have reported the results of two phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Laura E., Olson, Brian M., McNeel, Douglas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514519/
https://www.ncbi.nlm.nih.gov/pubmed/28716080
http://dx.doi.org/10.1186/s40425-017-0260-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514519/
https://www.ncbi.nlm.nih.gov/pubmed/28716080
http://dx.doi.org/10.1186/s40425-017-0260-3

Ejemplares similares